Share on StockTwits

Analysts at RBC Capital began coverage on shares of athenahealth (NASDAQ:ATHN) in a research report issued to clients and investors on Thursday, Analyst Ratings reports. The firm set a “sector perform” rating on the stock.

Several other analysts have also recently commented on the stock. Analysts at Cowen and Company upgraded shares of athenahealth from an “underperform” rating to a “market perform” rating in a research note on Thursday. They now have a $186.00 price target on the stock, up previously from $123.00. Separately, analysts at Goldman Sachs reiterated a “neutral” rating on shares of athenahealth in a research note on Monday. Finally, analysts at ISI Group raised their price target on shares of athenahealth from $143.00 to $176.00 in a research note on Friday, February 7th. Two analysts have rated the stock with a sell rating, ten have issued a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $149.50.

athenahealth (NASDAQ:ATHN) traded up 3.04% on Thursday, hitting $186.69. The stock had a trading volume of 626,338 shares. athenahealth has a one year low of $82.01 and a one year high of $184.82. The stock has a 50-day moving average of $142.3 and a 200-day moving average of $125.9. The company has a market cap of $6.979 billion and a P/E ratio of 2588.29.

athenahealth (NASDAQ:ATHN) last posted its quarterly earnings results on Thursday, February 6th. The company reported $0.57 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.45 by $0.12. The company had revenue of $171.60 million for the quarter, compared to the consensus estimate of $168.39 million. During the same quarter last year, the company posted $0.29 earnings per share. athenahealth’s revenue was up 47.5% compared to the same quarter last year. Analysts expect that athenahealth will post $1.07 EPS for the current fiscal year.

In other athenahealth news, Director Dev Ittycheria sold 2,000 shares of the stock in a transaction dated Wednesday, February 12th. The shares were sold at an average price of $181.17, for a total transaction of $362,340.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

athenahealth, Inc (NASDAQ:ATHN), is a business services company, which provides ongoing billing, clinical-related, and other related services to its customers.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.